Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

REGENERON PHARMACEUTICALS, INC. (REGN) Insider Trading

4 open-market trades reported since Sep 3, 2026: 0 purchases worth $0 and 4 sales worth $5.55M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Andrew J. MurphyCo-Chief Scientific Officer0$01$3.20MOct 15, 2026
Marion McCourtEVP0$02$2.00MSep 3, 2026
Kathryn GuariniDirector0$01$340KSep 3, 2026

All trades

REGN insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 15Oct 14Andrew J. MurphyCo-Chief Scientific OfficerCo-Chief Scientific Officer▼ SELL10b5-14,147772.70$3.20M−7.4%Form 4 ↗
Sep 3Sep 2Marion McCourtEVPEVP▼ SELL10b5-11,215850.00$1.03M−8.5%Form 4 ↗
Sep 3Sep 3Marion McCourtEVPEVP▼ SELL10b5-11,131857.39$970K−8.6%Form 4 ↗
Sep 3Sep 2Kathryn GuariniDirectorDirector▼ SELL10b5-1400850.00$340K−40%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings